CME Group Inc.
CME Group Shareholders Re-elect Directors and Approve Compensation at 2025 Annual Meeting
Summary
CME Group Inc. held its 2025 Annual Meeting of Shareholders on May 8, 2025. The meeting's key outcomes included the re-election of fourteen Equity Directors, the ratification of Ernst & Young LLP as the independent public accounting firm for 2025, and the approval of the advisory vote on executive compensation. However, no quorum was achieved in the elections for Class B-1, Class B-2, and Class B-3 Directors, resulting in holdover directors continuing in their roles. The results were based on the votes of Class A and Class B shareholders.
Get alerts for CME
Be first to know when CME Group Inc. files with the SEC.
Filing Categories
Advertisement
About CME Group Inc.
CME Group Inc. is a leading global marketplace for derivatives and futures trading. It provides a diverse range of products, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals. CME Group's primary function is to facilitate risk management and price discovery, offering a centralized marketplace where traders can hedge against fluctuations in these various markets. Notable features include its electronic trading platform, CME Globex, enabling seamless access to its services worldwide, and its clearing services, ensuring the integrity and stability of the financial system. CME Group is crucial for market participants who require precise risk management tools, boasting significant influence in sectors like agriculture, energy, and global finance. As one of the largest futures and options exchanges, CME Group plays a pivotal role in the financial market by providing liquidity, transparency, and efficiency in trading activities.
Official SEC Documents
Advertisement